Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma
Clinical trial NCT03110562 · COMPLETED
Trial details
- NCT number
- NCT03110562
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-24
- Primary completion
- 2020-02-18
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.